Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.

Insinga RP, Laessig RH, Hoffman GL.

J Pediatr. 2002 Oct;141(4):524-31. Erratum in: J Pediatr. 2003 Jan;142(1):56..

PMID:
12378192
2.

Newborn screening for inborn errors of metabolism: a systematic review.

Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH.

Health Technol Assess. 1997;1(11):i-iv, 1-95. Review.

3.

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S.

Health Technol Assess. 2004 Mar;8(12):iii, 1-121. Review.

4.

[Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].

Simonsen H.

Ugeskr Laeger. 2002 Nov 25;164(48):5607-12. Review. Danish.

PMID:
12523003
5.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

6.

Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.

Tajima G, Sakura N, Yofune H, Nishimura Y, Ono H, Hasegawa Y, Hata I, Kimura M, Yamaguchi S, Shigematsu Y, Kobayashi M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 5;823(2):122-30. Review.

PMID:
16046200
7.
8.

Newborn screening.

Wilcken B, Wiley V.

Pathology. 2008 Feb;40(2):104-15. doi: 10.1080/00313020701813743. Review.

PMID:
18203033
9.

Economics of tandem mass spectrometry screening of neonatal inherited disorders.

Pandor A, Eastham J, Chilcott J, Paisley S, Beverley C.

Int J Technol Assess Health Care. 2006 Summer;22(3):321-6. Review.

PMID:
16984060
10.

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.

Health Technol Assess. 2004 May;8(20):iii, 1-78. Review.

11.

A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.

Thomason MJ, Lord J, Bain MD, Chalmers RA, Littlejohns P, Addison GM, Wilcox AH, Seymour CA.

J Public Health Med. 1998 Sep;20(3):331-43. Review.

PMID:
9793900
12.

Structural neuroimaging in psychosis: a systematic review and economic evaluation.

Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads C.

Health Technol Assess. 2008 May;12(18):iii-iv, ix-163. Review.

13.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
14.

Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.

Rhead WJ.

J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):370-7. Review.

PMID:
16763904
15.

Cost-effectiveness of single-level anterior cervical discectomy and fusion for cervical spondylosis.

Angevine PD, Zivin JG, McCormick PC.

Spine (Phila Pa 1976). 2005 Sep 1;30(17):1989-97. Review.

PMID:
16135991
16.

Application of electrospray tandem mass spectrometry to neonatal screening.

Rashed MS, Rahbeeni Z, Ozand PT.

Semin Perinatol. 1999 Apr;23(2):183-93. Review.

PMID:
10331469
17.

Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.

Knight C, Hind D, Brewer N, Abbott V.

Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. Review.

18.
19.

Tandem spectrometry in newborn screening.

Seashore MR.

Curr Opin Pediatr. 1998 Dec;10(6):609-14. Review.

PMID:
9848021
20.

Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, Nicholl J, Nicholson P, Tunaley JR, Virdi NK.

Health Technol Assess. 1997;1(7):i-iv, 1-202. Review.

Supplemental Content

Support Center